1. Pharmacological management of severe plaque psoriasis in patients with cardiovascular disease
   Stefano Piaserico et al, 2022, Expert Opinion on Pharmacotherapy CrossRef
2. Ischemic heart disease in correlation with some immunological parameters
   Wisal Salman Abd et al, 2023, INTERNATIONAL CONFERENCE OF COMPUTATIONAL METHODS IN SCIENCES AND ENGINEERING ICCMSE 2021 CrossRef
3. Targeting the JAK2/STAT3 signaling pathway with natural plants and phytochemical ingredients: A novel therapeutic method for combatting cardiovascular diseases
   Bing Guo et al, 2024, Biomedicine & Pharmacotherapy CrossRef
4. High expression of IL6 and decrease in immune cells in COVID-19 patients combined with myocardial injury
   Tingting Chen et al, 2023, Frontiers in Immunology CrossRef
5. Upregulated E3 ligase tripartite motif‐containing protein 21 in psoriatic epidermis ubiquitylates nuclear factor‐κB p65 subunit and promotes inflammation in keratinocytes*
   L. Yang et al, 2021, British Journal of Dermatology CrossRef
6. Signaling pathways of inflammation in myocardial ischemia/reperfusion injury
   Shi-Yu Hu et al, 2022, Cardiology Plus CrossRef
7. Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges
   Jing Ye et al, 2020, Frontiers in Pharmacology CrossRef
8. IκB Kinase-β Regulates Neutrophil Recruitment Through Activation of STAT3 Signaling in the Esophagus
   Kelsey Nicole Wiles et al, 2021, Cellular and Molecular Gastroenterology and Hepatology CrossRef
9. Age-associated declined function of endothelial progenitor cells and its correlation with plasma IL-18 or IL-23 concentrations in patients with ST-segment elevation myocardial infarction
   Yuanting Zhu et al, 2024, Frontiers in Cardiovascular Medicine CrossRef
10. IL-23R Signaling Plays No Role in Myocardial Infarction
    Erika Engelowski et al, 2018, Scientific Reports CrossRef
11. The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis
    A. Egeberg et al, 2020, Journal of the European Academy of Dermatology and Venereology CrossRef
12. Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
    Przemysław J. Kotyla et al, 2020, International Journal of Molecular Sciences CrossRef
13. Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS1
    Jun Zhang et al, 2023, Hämostaseologie CrossRef
14. Crocin prevents platelet‑derived growth factor BB‑induced vascular smooth muscle cells proliferation and phenotypic switch
    Lijian Tong et al, 2018, Molecular Medicine Reports CrossRef
15. JAK-inhibitors: clinical pharmacology and application perspectives
    Svetlana A. Doktorova et al, 2023, Reviews on Clinical Pharmacology and Drug Therapy CrossRef
16. Regulatory effects of trimetazidine in cardiac ischemia/reperfusion injury
    Mohammad Hosein Farzaei et al, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
17. Cloning and Expression of the Tibetan Pig Interleukin-23 Gene and Its Promotion of Immunity of Pigs to PCV2 Vaccine
    Yongle Xiao et al, 2020, Vaccines CrossRef
18. IL-22 relieves hepatic ischemia-reperfusion injury by inhibiting mitochondrial apoptosis based on the activation of STAT3
    Zhengchen Jiang et al, 2024, The International Journal of Biochemistry & Cell Biology CrossRef
19. BMSC‑derived exosome‑mediated miR‑25‑3p delivery protects against myocardial ischemia/reperfusion injury by constraining M1‑like macrophage polarization
    Jingxia Du et al, 2024, Molecular Medicine Reports CrossRef